MétaCan
Menu
Back to cohort
Record W3081136664 · doi:10.2217/cer-2020-0095

Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy

2020· review· en· W3081136664 on OpenAlexaff
Craig Campbell, Richard J. Barohn, Enrico Bertini, B. Chabrol, Giacomo P. Comi, Basil T. Darras, Richard S. Finkel, Kevin M. Flanigan, Nathalie Goemans, Susan T. Iannaccone, Kristi Jones, Janbernd Kirschner, Jean K. Mah, Craig M. McDonald, Eugenio Mercuri, Yoram Nevo, Yann Péréon, J. Ben Renfroe, Monique M. Ryan, Jacinda B. Sampson, Ulrike Schara, Thomas Sejersen, Kathryn Selby, M. Tulinius, Juan J. Vílchez, Thomas Voït, L. J. Wei, Brenda Wong, Gary Elfring, Marcio Ferreira de Souza, Joseph McIntosh, Panayiota Trifillis, Stuart W. Peltz, Francesco Muntoni

Bibliographic record

VenueJournal of Comparative Effectiveness Research · 2020
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMuscle Physiology and Disorders
Canadian institutionsBC Children's HospitalUniversity of CalgaryAlberta Children's HospitalWestern University
FundersNational Institutes of HealthMinistero della SaluteCytokineticsParent Project Muscular DystrophyFondazione TelethonPTC TherapeuticsMuscular Dystrophy AssociationSarepta TherapeuticsIonis PharmaceuticalsFibroGenAveXisBiogenBristol-Myers Squibb
KeywordsMedicineDuchenne muscular dystrophyPlaceboInternal medicineRandomized controlled trialAmbulatoryNonsense mutationMeta-analysisSubgroup analysisPhysical therapyMutationGenetics

Abstract

fetched live from OpenAlex

Aim: Assess the totality of efficacy evidence for ataluren in patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). Materials & methods: Data from the two completed randomized controlled trials (ClinicalTrials.gov: NCT00592553; NCT01826487) of ataluren in nmDMD were combined to examine the intent-to-treat (ITT) populations and two patient subgroups (baseline 6-min walk distance [6MWD] ≥300–<400 or <400 m). Meta-analyses examined 6MWD change from baseline to week 48. Results: Statistically significant differences in 6MWD change with ataluren versus placebo were observed across all three meta-analyses. Least-squares mean difference (95% CI): ITT (n = 342), +17.2 (0.2–34.1) m, p = 0.0473; ≥300–<400 m (n = 143), +43.9 (18.2–69.6) m, p = 0.0008; <400 m (n = 216), +27.7 (6.4–49.0) m, p = 0.0109. Conclusion: These meta-analyses support previous evidence for ataluren in slowing disease progression versus placebo in patients with nmDMD over 48 weeks. Treatment benefit was most evident in patients with a baseline 6MWD ≥300–<400 m (the ambulatory transition phase), thereby informing future trial design.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.023
metaresearch head score (Gemma)0.037
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.023
Threshold uncertainty score0.120

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0230.037
Meta-epidemiology (narrow)0.0040.002
Meta-epidemiology (broad)0.0170.052
Bibliometrics0.0040.004
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0020.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.512
GPT teacher head0.574
Teacher spread0.062 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations63
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Comparative Effectiveness ResearchSame topicMuscle Physiology and DisordersFrench-language works237,207